Healthcare & Medical Devices Global On demand · 24-48h

Global Hospital Sterilization Outsourcing Service for Medical Devices Market Strategic Research Report

Global Hospital Sterilization Outsourcing Service for Medica…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Hospital Sterilization Outsourcing Service for Medical Devices Market
$10.51B2025
8.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: High-temperature Sterilization, Low-temperature Sterilization, Other

By Application: In The Hospital, Outside The Hospital

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: STERIS, Crothall Healthcare, Sterigenics (Sotera Health), SERVIZI ITALIA S.P.A., AIR WATER INC, Nihon Stery, Inc (H.U. Group), Servizi Ospedalieri, Shanghai Julikang, PENTAX Medical, Laoken Medical Technology, SpecialtyCare, Steriguard, Antesu, IHSS, Apperton, Instruclean GmbH, Cretex Companies, Life Science Outsourcing, Surgical Solutions, Steritalia S.p.A. (DUSSMANN), Scapa Healthcare, MVO Stérilisation, Jinghong Medical, BGS Beta-Gamma-Service GmbH, Servica, Medistri SA

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 172 pages
Market size 2025
$10.51B
Billion USD
Forecast CAGR
8.9%
2025-2032
Forecast 2032
$19.1B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Hospital Sterilization Outsourcing Service for Medical Devices market size is predicted to grow from US$ 10,508 million in 2025 to US$ 18,711 million in 2032; it is expected to grow at a CAGR of 8.9% from 2026 to 2032.

Hospital Sterilization Outsourcing Service for Medical Devices refers to the centralized or decentralized sterilization operations within a healthcare facility that processes, sterilizes, and maintains the sterility of medical devices, surgical instruments, and other reusable equipment used in patient care. These services are essential for preventing healthcare-associated infections (HAIs) and ensuring that medical instruments are safe for use in clinical procedures. Sterilization services within hospitals are typically managed by specialized departments such as the Sterile Processing Department (SPD) or Central Sterile Services Department (CSSD), which are responsible for handling the end-to-end process of sterilization, from receiving soiled equipment to delivering it back sterile and ready for use.

For large hospitals, despite possessing sterilization supply capabilities, the increasing demands for sophisticated instrument sterilization and the growing surgical volume, coupled with limitations in space expansion and operating costs, are gradually revealing the capacity bottlenecks and technological upgrade pressures of self-built centers. Hospital Sterilization Outsourcing Service for Medical Devices, with its concentrated investment in high-end equipment and professional technical teams, can undertake complex sterilization services, helping hospitals free up internal resources and focus on core diagnostic and treatment services. For small and medium-sized medical institutions, often limited by funding and scale, the construction and maintenance costs of standardized sterilization centers are difficult to bear. Self-conducting sterilization services can easily lead to substandard quality and weak risk control. Hospital Sterilization Outsourcing Service for Medical Devices, by integrating scattered sterilization needs into a large-scale service, effectively reduces unit service costs, enabling small and medium-sized medical institutions to obtain sterilization services that meet national standards with lower investment, reducing operational burdens and mitigating infection control risks.

Policy guidance and regulation have laid a solid foundation for the development of Hospital Sterilization Outsourcing Service for Medical Devices, while the urgent need of medical institutions to reduce costs and increase efficiency constitutes the core driving force for industry growth. Driven by these two factors, Hospital Sterilization Outsourcing Service for Medical Devices will gradually achieve full coverage of its service scope and a comprehensive upgrade of its service capabilities, becoming an important support for ensuring medical safety and promoting high-quality development of medical services.

Global key Hospital Sterilization Outsourcing Service for Medical Devices players cover STERIS, Crothall Healthcare, Sterigenics (Sotera Health), SERVIZI ITALIA S.P.A., AIR WATER INC, etc.

This report presents a comprehensive overview of the global Hospital Sterilization Outsourcing Service for Medical Devices market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • High-temperature Sterilization
  • Low-temperature Sterilization
  • Other

Segment by Service Content

  • Comprehensive Services
  • Specialized Services

Segment by Application

  • Hard Instruments
  • Soft Instruments
  • Others

Segment by Application

  • In The Hospital
  • Outside The Hospital

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Hospital Sterilization Outsourcing Service for Medical Devices market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in In The Hospital, Outside The Hospital evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Hospital Sterilization Outsourcing Service for Medical Devices Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 8.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$10.51B
2025
Forecast
$19.1B
2032
CAGR
8.9%
2025–2032
Regions
5
global
Key companies
STERISCrothall HealthcareSterigenics (Sotera Health)SERVIZI ITALIA S.P.A.AIR WATER INCNihon SteryInc (H.U. Group)Servizi Ospedalieri
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
High-temperature SterilizationLow-temperature SterilizationOther
By Application
In The HospitalOutside The Hospital

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 High-temperature Sterilization
  • 3.1.3 Low-temperature Sterilization
  • 3.1.4 Other
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 In The Hospital
  • 4.1.3 Outside The Hospital
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 STERIS
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Crothall Healthcare
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Sterigenics (Sotera Health)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 SERVIZI ITALIA S.P.A.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 AIR WATER INC
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Nihon Stery , Inc (H.U. Group)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Servizi Ospedalieri
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shanghai Julikang
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 PENTAX Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Laoken Medical Technology
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 SpecialtyCare
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Steriguard
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Antesu
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 IHSS
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Apperton
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Instruclean GmbH
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Cretex Companies
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Life Science Outsourcing
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Surgical Solutions
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Steritalia S.p.A. (DUSSMANN)
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Scapa Healthcare
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 MVO Stérilisation
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Jinghong Medical
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 BGS Beta-Gamma-Service GmbH
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Servica
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 Medistri SA
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Hospital Sterilization Outsourcing Service for Medical Devices market?
The global Hospital Sterilization Outsourcing Service for Medical Devices market is estimated at US$ 10.51 billion in 2025 (base year) and is projected to reach US$ 18.71 billion by 2032.
How fast is the Hospital Sterilization Outsourcing Service for Medical Devices market expected to grow?
The market is expected to grow at a CAGR of 8.9% from 2026 to 2032, expanding from US$ 10.51 billion in 2025 to US$ 18.71 billion in 2032, roughly 1.8 times its base-year value.
What does the Hospital Sterilization Outsourcing Service for Medical Devices market cover?
Hospital Sterilization Outsourcing Service for Medical Devices refers to the centralized or decentralized sterilization operations within a healthcare facility that processes, sterilizes, and maintains the sterility of medical devices, surgical instruments, and other reusable equipment used in patient care. These services are essential for preventing healthcare-associated infections (HAIs) and ensuring that medical instruments are safe for use in clinical procedures.
What are the main segments of the Hospital Sterilization Outsourcing Service for Medical Devices market by type?
By type, the market is segmented into High-temperature Sterilization, Low-temperature Sterilization and Other.
Which applications drive demand in the Hospital Sterilization Outsourcing Service for Medical Devices market?
Key applications covered include In The Hospital and Outside The Hospital.
Who are the key players in the Hospital Sterilization Outsourcing Service for Medical Devices market?
Key players profiled include STERIS, Crothall Healthcare, Sterigenics (Sotera Health), SERVIZI ITALIA S.P.A., AIR WATER INC, Nihon Stery , Inc (H.U. Group), Servizi Ospedalieri and Shanghai Julikang, among 26 companies covered in total.
Which regions and countries are covered for Hospital Sterilization Outsourcing Service for Medical Devices?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Hospital Sterilization Outsourcing Service for Medical Devices market?
Policy guidance and regulation have laid a solid foundation for the development of Hospital Sterilization Outsourcing Service for Medical Devices, while the urgent need of medical institutions to reduce costs and increase efficiency constitutes the core driving force for industry growth.
What challenges does the Hospital Sterilization Outsourcing Service for Medical Devices market face?
For large hospitals, despite possessing sterilization supply capabilities, the increasing demands for sophisticated instrument sterilization and the growing surgical volume, coupled with limitations in space expansion and operating costs, are gradually revealing the capacity bottlenecks and technological upgrade pressures of self-built centers.
Who should buy the Hospital Sterilization Outsourcing Service for Medical Devices market report?
The report is intended for manufacturers and solution providers, distributors and end users in In The Hospital and Outside The Hospital, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Hospital Sterilization Outsourcing Service for Medical Devices market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.